Natasa M Milic1, Elisabeth Codsi2, Yvonne S Butler Tobah2, Wendy M White2, Andrea G Kattah3, Tracey L Weissgerber3, Mie Saiki3, Santosh Parashuram3, Lisa E Vaughan4, Amy L Weaver4, Marko Savic5, Michelle M Mielke6, Vesna D Garovic7. 1. Division of Nephrology and Hypertension, University of Belgrade, Belgrade, Serbia; Department of Biostatistics, Medical Faculty, University of Belgrade, Belgrade, Serbia. 2. Department of Obstetrics and Gynecology, Mayo Clinic College of Medicine and Science, Mayo Clinic, Rochester, MN. 3. Division of Nephrology and Hypertension, University of Belgrade, Belgrade, Serbia. 4. Division of Biomedical Statistics and Informatics, Mayo Clinic College of Medicine and Science, Mayo Clinic, Rochester, MN. 5. Department of Biostatistics, Medical Faculty, University of Belgrade, Belgrade, Serbia. 6. Department of Health Sciences Research and Department of Neurology, Mayo Clinic College of Medicine and Science, Mayo Clinic, Rochester, MN. 7. Division of Nephrology and Hypertension, University of Belgrade, Belgrade, Serbia; Department of Obstetrics and Gynecology, Mayo Clinic College of Medicine and Science, Mayo Clinic, Rochester, MN. Electronic address: garovic.vesna@mayo.edu.
Abstract
OBJECTIVES: To develop and validate criteria for the retrospective diagnoses of hypertensive disorders of pregnancy that would be amenable to the development of an electronic algorithm, and to compare the accuracy of diagnoses based on both the algorithm and diagnostic codes with the gold standard, of physician-made diagnoses based on a detailed review of medical records using accepted clinical criteria. PATIENTS AND METHODS: An algorithm for hypertensive disorders of pregnancy was developed by first defining a set of criteria for retrospective diagnoses, which included relevant clinical variables and diagnosis of hypertension that required blood pressure elevations in greater than 50% of readings ("the 50% rule"). The algorithm was validated using the Rochester Epidemiology Project (Rochester, Minnesota). A stratified random sample of pregnancies and deliveries between January 1, 1976, and December 31, 1982, with the algorithm-based diagnoses was generated for review and physician-made diagnoses (normotensive, gestational hypertension, and preeclampsia), which served as the gold standard; the targeted cohort size for analysis was 25 per diagnosis category according to the gold standard. Agreements between (1) algorithm-based diagnoses and (2) diagnostic codes and the gold standard were analyzed. RESULTS: Sensitivities of the algorithm for 25 normotensive pregnancies, 25 with gestational hypertension, and 25 with preeclampsia were 100%, 88%, and 100%, respectively, and specificities were 94%, 100%, and 100%, respectively. Diagnostic code sensitivities were 96% for normotensive pregnancies, 32% for gestational hypertension, and 96% for preeclampsia, and specificities were 78%, 96%, and 88%, respectively. CONCLUSION: The electronic diagnostic algorithm was highly sensitive and specific in identifying and classifying hypertensive disorders of pregnancy and was superior to diagnostic codes.
OBJECTIVES: To develop and validate criteria for the retrospective diagnoses of hypertensive disorders of pregnancy that would be amenable to the development of an electronic algorithm, and to compare the accuracy of diagnoses based on both the algorithm and diagnostic codes with the gold standard, of physician-made diagnoses based on a detailed review of medical records using accepted clinical criteria. PATIENTS AND METHODS: An algorithm for hypertensive disorders of pregnancy was developed by first defining a set of criteria for retrospective diagnoses, which included relevant clinical variables and diagnosis of hypertension that required blood pressure elevations in greater than 50% of readings ("the 50% rule"). The algorithm was validated using the Rochester Epidemiology Project (Rochester, Minnesota). A stratified random sample of pregnancies and deliveries between January 1, 1976, and December 31, 1982, with the algorithm-based diagnoses was generated for review and physician-made diagnoses (normotensive, gestational hypertension, and preeclampsia), which served as the gold standard; the targeted cohort size for analysis was 25 per diagnosis category according to the gold standard. Agreements between (1) algorithm-based diagnoses and (2) diagnostic codes and the gold standard were analyzed. RESULTS: Sensitivities of the algorithm for 25 normotensive pregnancies, 25 with gestational hypertension, and 25 with preeclampsia were 100%, 88%, and 100%, respectively, and specificities were 94%, 100%, and 100%, respectively. Diagnostic code sensitivities were 96% for normotensive pregnancies, 32% for gestational hypertension, and 96% for preeclampsia, and specificities were 78%, 96%, and 88%, respectively. CONCLUSION: The electronic diagnostic algorithm was highly sensitive and specific in identifying and classifying hypertensive disorders of pregnancy and was superior to diagnostic codes.
Authors: Leslie Myatt; Christopher W Redman; Anne Cathrine Staff; Stefan Hansson; Melissa L Wilson; Hannele Laivuori; Lucilla Poston; James M Roberts Journal: Hypertension Date: 2014-03-31 Impact factor: 10.190
Authors: Marianne Coolman; Christianne J M de Groot; Vincent W Jaddoe; Albert Hofman; Hein Raat; Eric A P Steegers Journal: J Clin Epidemiol Date: 2010-03-02 Impact factor: 6.437
Authors: Jennifer J Stuart; C Noel Bairey Merz; Sarah L Berga; Virginia M Miller; Pamela Ouyang; Chrisandra L Shufelt; Meir Steiner; Nanette K Wenger; Janet W Rich-Edwards Journal: J Womens Health (Larchmt) Date: 2012-12-06 Impact factor: 2.681
Authors: V Bergink; T M Laursen; B M W Johannsen; S A Kushner; S Meltzer-Brody; T Munk-Olsen Journal: Psychol Med Date: 2015-08-05 Impact factor: 7.723
Authors: Vesna D Garovic; Wendy M White; Lisa Vaughan; Mie Saiki; Santosh Parashuram; Oscar Garcia-Valencia; Tracey L Weissgerber; Natasa Milic; Amy Weaver; Michelle M Mielke Journal: J Am Coll Cardiol Date: 2020-05-12 Impact factor: 24.094
Authors: Lisa Vaughan; Wendy M White; Yvonne S Butler Tobah; Andrea Kattah; Santosh Parashuram; Madugodarlalalage D Gunaratne; Jane V Vermunt; Michelle Mielke; Natasa M Milic; Sonja Suvakov; Suzette Bielinski; Alanna M Chamberlain; Vesna D Garovic Journal: BMJ Open Date: 2022-04-26 Impact factor: 3.006